TBP — Tetra Bio Pharma Share News
0.000.00%
HealthcareSpeculativeMicro Cap
Brief: Tetra Bio-Pharma Announces Pricing Of Marketed Public Offering Of Units (Dec. 14)
Advisory: Alert on Tetra Bio Pharma offer pricing of units withdrawn
Brief: Tetra Bio-Pharma Reports Positive Initial Data from Both Ongoing Trials of QIXLEEF
Brief: Tetra Bio-Pharma Receives Positive Opinion For Orphan Drug Designation For Qixleef From The European Medicines Agency
Brief: Tetra Bio-Pharma Provides Update On Clinical Development Program For Qixleef
Brief: Tetra Bio-Pharma Receives Positive Scientific Advice Assessment (Saa) Report For Qixleef™
Brief: Tetra Bio-Pharma Files Percent Patent Application For Cannabis Plant Residue
Brief: Tetra Bio-Pharma Accelerates Reborn1 Trial
Advisory: Alert on Tetra Bio-Pharma's CFO appointment withdrawn
Advisory: Alert on Tetra Bio-Pharma's CFO appointment withdrawn
Brief: Tetra Bio-Pharma Says Jean-François Boily Has Resigned As Chief Financial Officer Of Co Effective July 16, 2021
Brief: Tetra Bio Pharma Inc Significant Discovery Reveals New Antiviral Properties Of Tetra Bio-Pharma's Innovative Drug Ards-003
Brief: Tetra Bio-Pharma Announces Clinical Advancements And Establishment Of At-The-Market Equity Program
Brief: Tetra Bio-Pharma Announces Changes To Board
Brief: Tetra Bio-Pharma Announces Closing Of Bought Deal Offering
Brief: Tetra Bio-Pharma Announces $10 Mln "Bought Deal" Public Offering
Canada Stocks: TSX gains as investors cheer positive corporate earnings
Brief: Tetra Bio-Pharma Reports $10 Mln Bought Deal Offering Of Units
Brief: Tetra Bio-Pharma, Mondias Enter Final Agreement For Purchase Of Lumiera Health Innovation Inc